BetaEntity Annotation Prototype

Entity family

Browse diseases

Named diseases, disorders, syndromes, injuries, and health conditions. Examples include epilepsy, diabetes, stroke.

40articles mentioning diseases
51disease mentions
1distinct diseases extracted
0%of mentions human-reviewed
Active filtersEntity: Metabolic Dysfunction-Associated Steatotic Liver Disease ×

Metabolic Dysfunction-Associated Steatotic Liver Disease

This disease is selected. Its supporting articles are shown below.

Articles mentioning Metabolic Dysfunction-Associated Steatotic Liver Disease

40 articles · page 3 of 4

Navigating the benefits and harms of GLP-1 and GLP-1/GIP agonists in obesity

dtb · abstract · 2026-01-28 · 1 matching annotations

96.8%
type 2 diabetes mellitusmetabolic dysfunction-associated steatotic liver diseasecardiovascular diseasethyroid cell tumoursnon-arteritic anterior ischaemic optic neuropathyobesityGLP-1 RAindividualised dietetic advice

…oss results in undoubted improvements. These conditions include type 2 diabetes mellitus, cardiovascular disease and metabolic dysfunction-associated st…

Metabolic dysfunction and alcohol-associated liver disease (MetALD)

egastro · abstract · 2025-12-25 · 1 matching annotations

91.1%
hepatocellular carcinomametabolic dysfunction-associated steatotic liver diseaseMetALDtype 2 diabetes mellitussteatohepatitisalcohol-associated liver diseaseMetabolic dysfunction and alcohol-associated liver diseasefibrosis

…act synergistically to accelerate steatohepatitis, fibrosis and hepatocellular carcinoma. However, the precise mechanisms underlying liver injury in Met…

MASLDtype 2 diabetesMASLD-related MALOMyocardial infarctionangina pectorismetabolic dysfunction-associated steatotic liver diseaseSwedish National Patient Register

…d comorbidities were present at lower rates in individuals with MASLD without MALO and population controls (p<0.001).Conclusions Pati…

CD47: an immunoregulatory nexus in liver and gastrointestinal disorders

egastro · abstract · 2025-10-13 · 1 matching annotations

92.1%
metabolic dysfunction-associated steatotic liver diseasealcohol-related liver diseasehepatic encephalopathyRifaximinNational Institute of Health and Care ExcellenceRStudioEur J Gastroenterol Hepatol

…attributed to higher rates of alcohol-related liver disease and metabolic dysfunction-associated steatotic liver disease. Rifaximin, indicated for the secondary prevention of recurrent…

metabolic syndromecirrhosismetabolic dysfunction-associated steatohepatitisMetabolic dysfunction-associated steatotic liver diseaseHCCMASLDBritish Liver Trustdrug therapy

…ent, a Fibroscan, and completion liver screen. Interrogation of metabolic syndrome risk factors and alcohol screening takes place, with appropriat…